Home MarketAjanta Pharma Ltd.

Ajanta Pharma Ltd. Stock Info: As on 2018-05-24 15:56:20

Nse

977.60

-9.40(-0.95%)
Change%
52 Week Range
962.35
22.00
1,696.95
23.00
Open994.20
Day's Range888.30 - 1,085.70
Value Traded (in ₹ Cr.) 52.88

Bse

981.90

-3.10(-0.31%)
Change %
52 Week Range
963.35
22.00
1,700.35
23.00
Open976.00
Day's Range886.50 - 1,083.50
Value Traded (in ₹ Cr.) 1.22

Stock Exchange

Category No. Of Shares Share %
ForeignPromoters 0.00 0.00%
IndianPromoters 62,229,759.00 70.70%
Mutual Funds/UTI 5,407,265.00 6.14%
FII 10,707,666.00 12.17%
Employee 0.00 0.00%
Public 7,997,932.00 9.09%
Government 238,875.00 0.27%
Others 1,084,376.00 1.23%
More

Key Statistics

Valuation Measures
Market Cap / Sales Ratio 8.54
Basic EPS (Rs.) 56.79
Cash EPS 63.23
BVPerShare Excl 170.03
Operating Revenue 206.07
PBDITPerShare 79.48
Dividend 13.00
NPPerShare 56.51
Current Ratio 4.06
Quick Ratio 3.12
PriceToBV 10.35
Earnings 0.03
PBDIT Margin 38.56
PBT Margin 35.14
NP Margin 27.42
Return On Assets 28.97
Retention Ratios 77.10
Parameter Mar-17 (₹ Cr.) Yoy%change
Total Income 1,889.66
Total Expenses 1,249.01
EBITDA 702.96
PBT 640.65
PAT 499.81
Net Income 499.81
More
Parameter Mar-18 (₹ Cr.) 6M % change
Total Income 1,034.07
Total Expenses 724.65
EBITDA 279.16
PBT 309.27
PAT 243.09
Net Income 0.00
More
Total Assets
Total Assets
Parameter Mar-17 (₹ Cr.) Yoy%change
Total share capital 17.69
Net worth 1,503.94
Investments 198.82
Total Liability 1,724.86
Total debt 5.53
Net block 912.19
Total Assets 1,724.86
Parameter Mar-17 (₹ Cr.) 6M % change
Total share capital 17.69
Net worth 1,124.79
Investments 83.64
Total Liability 1,414.90
Total debt 59.87
Net block 672.63
Total Assets 1,414.90
Company Curr Price Prev. Close Change% W's Low/High

Aarti Drugs Ltd.

533.05 531.95 0.21
524.95580

Abbott India Ltd.

6671.7 6587.45 1.28
65106890

Albert David Ltd.

362.35 362.75 -0.11
356.2383.15

Alembic Ltd.

48.85 50.8 -3.84
50.254

Alembic Pharmaceuticals Ltd.

420.7 422.3 -0.38
418.5491.2

Alkem Laboratories Ltd.

1957.55 1965.35 -0.4
18882036.65

Alpa Laboratories Ltd.

32.1 32.55 -1.38
31.5534.4
Company Curr Price Prev. Close Change% W's Low/High

Aarey Drugs & Pharmaceuticals Ltd.

47.5 49.05 -3.16
46.351.55

Aarti Drugs Ltd.

530 529.15 0.16
526585

Aayush Food & Herbs Ltd.

47.7 48.1 -0.83
4355

Abbott India Ltd.

6699.95 6593.7 1.61
6465.056872.5

ABL Bio-Technologies Ltd.

0.81 0.78 3.85
0.750.81

Addlife Pharma Ltd.

0.46 0 0
0.460.5

Adinath Bio-Labs Ltd.

0.3 0.31 -3.23
0.30.3
More
Parameter Mar-17(in ₹ Cr.)
Cash from operating activities 529.06
Cash from investing activities -349.66
Cash from financing activities -194.08
Net change in cash -14.68

Stock Held By Mutual Fund Schemes

Corporate Details

About Management

2005 -Max Healthcare to establish India`s first brain lab in New Delhi -Max India Ltd Max telecom ventures Ltd signed a MoU 2008 -Max India signs agreement with UK firm for health insurance biz 2012 -Board declares Interim Dividend of 500% i.e. Rs. 10/- for every equity share of Rs. 2/- each to the shareholders. -Ajanta Pharma Ltd has splits its face value from Rs 10/- to 5/- 2013 - Board recommends Final Dividend 610% amounting to Rs. 12.20 per equity share of Rs. 2/- each to the shareholders. -Ajanta Pharma has announces bonus in the ratio of 1:2 2014 -Board recommends Final Dividendof 90%, i.e., Rs. 1.80 for every equity share of Rs. 2/- each to the shareholders 2015 -Ajanta Pharma Announces the Launch of Montelukast Sodium Oral Granules -Launch of Montelukast lR Tablets and Montelukast Chewable Tablets in US market -Fortune India presents award to Ajanta Pharma -Ajanta Pharma gets approvals for 3 ANDA's -Ajanta Pharma has splits its face value from Rs. 5 to Rs. 2 2017 -Ajanta Pharma gets USFDA nod for Duloxetine Hydrochloride. -Ajanta Pharma launches Eletriptan Hydrobromide Tablets. -Ajanta Pharma launches Clonidine Hydrochloride Extended Release Tablets in US. -Inaugurated & commissioned 1st phase at a New Facility in Guwahati, Assam, India - Dahej facility receives successful US FDA approval.

Registered Office

Mirza Palashbari Road, Mouza, Kamrup (R),

,,,      ,

Registrar Details

Link Intime India Pvt. Ltd.